Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Key protein alterations associated with hyperdynamic cardiac function: insights based on proteomic analysis of the protein phosphatase 1 inhibitor-1 overexpressing hearts.

Pathak A, Baldwin B, Kranias EG.

Hellenic J Cardiol. 2007 Jan-Feb;48(1):30-6. Erratum in: Hellenic J Cardiol. 2007 Nov-Dec;48(6):385.

2.

Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2.

Kirchhefer U, Baba HA, Bokník P, Breeden KM, Mavila N, Brüchert N, Justus I, Matus M, Schmitz W, Depaoli-Roach AA, Neumann J.

Cardiovasc Res. 2005 Oct 1;68(1):98-108.

PMID:
15975567
3.

Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling.

Chu G, Kerr JP, Mitton B, Egnaczyk GF, Vazquez JA, Shen M, Kilby GW, Stevenson TI, Maggio JE, Vockley J, Rapundalo ST, Kranias EG.

FASEB J. 2004 Nov;18(14):1725-7. Epub 2004 Sep 9.

PMID:
15358683
4.

Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure.

Dohke T, Wada A, Isono T, Fujii M, Yamamoto T, Tsutamoto T, Horie M.

J Card Fail. 2006 Feb;12(1):77-84.

PMID:
16500585
5.

Phosphoproteome analysis of cardiomyocytes subjected to beta-adrenergic stimulation: identification and characterization of a cardiac heat shock protein p20.

Chu G, Egnaczyk GF, Zhao W, Jo SH, Fan GC, Maggio JE, Xiao RP, Kranias EG.

Circ Res. 2004 Feb 6;94(2):184-93. Epub 2003 Nov 13.

6.

Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts.

Gupta RC, Mishra S, Rastogi S, Imai M, Habib O, Sabbah HN.

Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2373-81.

PMID:
14613911
7.

Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy.

El-Armouche A, Wittköpper K, Degenhardt F, Weinberger F, Didié M, Melnychenko I, Grimm M, Peeck M, Zimmermann WH, Unsöld B, Hasenfuss G, Dobrev D, Eschenhagen T.

Cardiovasc Res. 2008 Dec 1;80(3):396-406. doi: 10.1093/cvr/cvn208. Epub 2008 Aug 8.

PMID:
18689792
8.

Phospholamban: a key determinant of cardiac function and dysfunction.

Rodriguez P, Kranias EG.

Arch Mal Coeur Vaiss. 2005 Dec;98(12):1239-43. Review.

PMID:
16435604
9.

Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function.

Rodriguez P, Mitton B, Waggoner JR, Kranias EG.

J Biol Chem. 2006 Dec 15;281(50):38599-608. Epub 2006 Oct 17.

10.
11.

Proteomic analysis of cisplatin-induced cochlear damage: methods and early changes in protein expression.

Coling DE, Ding D, Young R, Lis M, Stofko E, Blumenthal KM, Salvi RJ.

Hear Res. 2007 Apr;226(1-2):140-56. Epub 2007 Jan 24.

PMID:
17321087
12.

Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics.

Kim N, Lee Y, Kim H, Joo H, Youm JB, Park WS, Warda M, Cuong DV, Han J.

Proteomics. 2006 Feb;6(4):1237-49.

PMID:
16402359
13.

Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts.

El-Armouche A, Pamminger T, Ditz D, Zolk O, Eschenhagen T.

Cardiovasc Res. 2004 Jan 1;61(1):87-93.

PMID:
14732205
14.

Alterations of mitochondrial enzymes contribute to cardiac hypertrophy before hypertension development in spontaneously hypertensive rats.

Meng C, Jin X, Xia L, Shen SM, Wang XL, Cai J, Chen GQ, Wang LS, Fang NY.

J Proteome Res. 2009 May;8(5):2463-75. doi: 10.1021/pr801059u.

PMID:
19265432
15.

Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function.

Gergs U, Boknik P, Buchwalow I, Fabritz L, Matus M, Justus I, Hanske G, Schmitz W, Neumann J.

J Biol Chem. 2004 Sep 24;279(39):40827-34. Epub 2004 Jul 6.

16.

Proteomic analysis of mitochondrial proteins in cardiomyocytes from chronic stressed rat.

Liu XH, Qian LJ, Gong JB, Shen J, Zhang XM, Qian XH.

Proteomics. 2004 Oct;4(10):3167-76.

PMID:
15378698
17.

Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems.

White MY, Cordwell SJ, McCarron HC, Prasan AM, Craft G, Hambly BD, Jeremy RW.

Proteomics. 2005 Apr;5(5):1395-410.

PMID:
15800873
18.

Proteomic characterization of protein phosphatase 1 complexes in ischemia-reperfusion and ischemic tolerance.

Cid C, Garcia-Bonilla L, Camafeita E, Burda J, Salinas M, Alcazar A.

Proteomics. 2007 Sep;7(17):3207-18.

PMID:
17683050
19.

Modulation of cytochrome C oxidase-va is possibly involved in metallothionein protection from doxorubicin cardiotoxicity.

Merten KE, Feng W, Zhang L, Pierce W, Cai J, Klein JB, Kang YJ.

J Pharmacol Exp Ther. 2005 Dec;315(3):1314-9. Epub 2005 Sep 6.

20.

Mitochondrial oxidative stress and dysfunction in myocardial remodelling.

Tsutsui H, Kinugawa S, Matsushima S.

Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Review.

PMID:
18854381

Supplemental Content

Support Center